GTBP - GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.